Compound Detail
CHEMBL3301581
ABALOPARATIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL3301581 |
| Name | ABALOPARATIDE |
| Phase | Approved |
| Structure Type | SEQ |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
8
Known Names
3
Indications
1
Mechanisms
Drug Information
| Molecule Type | Protein |
| First Approval | 2017 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Parathyroid hormone receptor agonist | AGONIST | Parathyroid hormone/parathyroid hormone-related peptide receptor | ✓ | ✓ |
Indications
Osteoporosis Osteoporosis, Postmenopausal Fractures, Bone
ATC Classification
H05AA04
abaloparatide
Level 1: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
Level 2: CALCIUM HOMEOSTASIS
Drug Warnings
Black Box Warning
carcinogenicity
Data from ChEMBL 36 via Core Engine